The largest database of trusted experimental protocols

5 protocols using cytodex 3 beads

1

HUVEC Fibrin Gel Bead Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HUVEC fibrin gel bead assay was performed as described (Nakatsu & Hughes, 2008 ). Briefly, EGM-2 complete medium was used to culture HUVECs 1 day before coating onto Cytodex 3 beads (Cat # C3275, Amersham Pharmacia Biotech, Erie, PA). About 400 HUVECs per bead were added to the FACS tube and were inverted to mix every 20 min for 4 h, followed by incubating overnight in T25 flasks. The next day, 500 cell-coated beads per well were mixed with fibrin gel composed of 2-μg·ml−1 fibrinogen (Sigma, F3879), 22-μ·ml−1 aprotinin (Sigma, A4529) and 0.625-U·ml−1 thrombin (Sigma, T6884). After clotting, 4000 HPFs in 1-ml EGM-2 complete medium containing the TAT-Sc or TAT-ANK were added to each fibrin gel. Medium containing SC-ANK or ANK was changed every day. The inverted microscope and ImageJ software were used to photograph and quantify sprouts. For isolating the mRNA of HUVECs in the fibrin gel, 3- and 4-mg·ml−1 trypsin (Sigma, T1426) were used to remove the pulmonary fibroblasts and fibrin gel, respectively. After complete digestion, the cell pellets from HUVECs from 12-well plate were resuspended in the TRIzol for RNA extraction.
+ Open protocol
+ Expand
2

Angiogenesis Inhibition Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ethanol, fibrinogen, aprotinin, thrombin and Pyrrolidine dithiocarbamate (PDTC) were purchased from Sigma Chemical Co. (St. Louis, MO). Cyanidin-3-glucoside (C3G) was prepared as previously described [38 (link)]. Anti-MCP1 and anti-VEGF antibodies were obtained from Abcam (Cambridge, MA). Anti-NF-κB p65, IκBα, p-IκBα and anti-LMNB1 antibodies were purchased from Protein Tech Group (Chicago, IL, USA). Anti-β-actin was obtained from Cell signaling Technology (Danvers, MA). Anti-CD31 antibody was obtained from BD Pharmingen (San Diego, CA). Reactive oxygen species detection reagents were obtained from Invitrogen Molecular Probes (Eugene, OR). MTT assay kit was purchased from Roche Molecular Biochemicals (Indianapolis, IN). Matrigel Invasion Chambers were purchased from BD Biosciences (Bedford, MA). Cytodex 3 beads were purchased from Amersham Pharmacia Biotech (Piscataway, NJ).
+ Open protocol
+ Expand
3

Fibrin Gel Bead Assay for Angiogenic Sprouting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fibrin gel bead assay for the study of angiogenic sprouting was performed as described previously.19 (link) In brief, Cytodex-3 beads (Amersham, Buckinghamshire, UK) were hydrated in phosphate buffered saline (PBS) and sterilized by autoclaving. ECs were trypsinized and mixed with beads at concentration of ~400 ECs per bead in 1 mL of warm EC growth medium in a fluorescence-activated cell sorting tube. The mixture was incubated for 4 hours at 37°C, with shaking the tube every 20 minutes. After that, the coated beads were transferred to a 6-well culture plate in 2 mL of EC growth medium and leave for 2 hours. After washed with EC growth medium, the coated beads were mixed with 2.0 mg/mL fibrinogen (Sigma-Aldrich, Munich, Germany) solution containing 0.15 U/mL of aprotinin (Sigma-Aldrich) and 0.625 U/mL of thrombin (Sigma-Aldrich) and then, added to each well of a 24-well plate. The plate was left for 5 minutes in the hood, and then, placed in the 37°C incubator for 10 minutes to generate a clot. Fibroblasts were then seeded on top of fibrin gel at a concentration of 20,000 cells per well. A total of 1 mL of EC growth medium per well was finally added. The media was changed every other day.
+ Open protocol
+ Expand
4

In vitro angiogenesis assay using fibrin gel beads

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro fibrin gel beads assay was carried out as previously described [57 ]. In brief, HUVECs transfected with either control siRNA or DIXDC1 siRNA were trypsinized and 1 × 106 HUVECs were coated on approximately 2500 Cytodex-3 beads (Amersham Biosciences, Catalog 17-0485-01) overnight at 37 °C. On the following day, the coated beads were washed 3 times with EGM-2 (Lonza, Catalog CC-3162) and 2.0 mg/ml fibrinogen type I (Sigma-Aldrich, Catalog F-8630) solution containing 0.15 U/ml aprotinin (Sigma-Aldrich, Catalog A-1153) at concentration of 500 beads/ml was added. Next, 0.625 U/ml Thrombin (Sigma-Aldrich, Catalog T-3399) was added to a 24-well plate and fibrinogen solution with beads was added to each well by pipetting 4–5 times. After clot formation, 20,000 fibroblasts in EGM-2 were added to each well. Pictures were taken every day for a week with a light microscope at a magnification of × 200. The number and lengths of the sprouts were analyzed using ImageJ.
+ Open protocol
+ Expand
5

Fibrin Gel Bead Angiogenesis Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCMEC were transfected with either Ad.METTL3 or Ad.Null, as mentioned above. Fibrin gel bead assay was performed, as previously described. 25 (link) Briefly, 1×10 6 HUVEC were mixed with 2500 Cytodex-3 Beads (Amersham) in EGM2 for 4 hours at 37 °C. Coated beads were transferred to T25 flask in 5 mL of EGM2 and left overnight. The following day, the coated beads were resuspended in fibrinogen solution (2.0 mg/mL fibrinogen, 0.15 Units/mL of aprotinin, Sigma-Aldrich) at a concentration of ≈200 beads/mL. Thrombin (0.625 Units/mL, Sigma-Aldrich) was added to each well of a 24-well plate before seeding 0.5 mL of the fibrinogen/bead suspension. Then, the plate was placed at 37 °C for 20 minutes to generate a clot, and 1 mL of EGM2 was added to each well. HUVEC were allowed to undergo morphogenesis for 2 to 3 days. Angiogenic sprouting was quantified by measuring cumulative sprout length, branches, sprouts, and the number of detached cells using NIH ImageJ software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!